We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+22.33%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$385B
AUM Growth
+$32.1B
Cap. Flow
-$35.1B
Cap. Flow %
-9.14%
Top 10 Hldgs %
30.5%
Holding
11,975
New
1,989
Increased
4,461
Reduced
4,218
Closed
1,130

Sector Composition

Rank Sector Weight
1 Technology 3.66%
2 Healthcare 3.16%
3 Industrials 2.01%
4 Financials 1.98%
5 Consumer Discretionary 1.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KXIN icon
10276
Kaixin Holdings
KXIN
$8.27M
0
SCTL
10277
CALL
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$71K ﹤0.01%
+24,900
New +$56.1K
LEAF
10278
PUT
DELISTED
Leaf Group Ltd.
LEAF
$71K ﹤0.01%
15,200
-2,500
-14% -$13.8K
CTIC
10279
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$71K ﹤0.01%
+22,041
New +$73.3K
BMRA icon
10280
PUT
Biomerica
BMRA
$4.48M
$70K ﹤0.01%
1,750
+337
+24% +$16.9K
BNED icon
10281
Barnes & Noble Education
BNED
$447M
$70K ﹤0.01%
+150
New +$49.6K
LXU icon
10282
PUT
LSB Industries
LXU
$708M
$70K ﹤0.01%
26,780
+13,780
+106% +$25K
NMR icon
10283
Nomura Holdings
NMR
$28.6B
$70K ﹤0.01%
13,060
-55,848
-81% -$276K
OXSQ icon
10284
Oxford Square Capital
OXSQ
$158M
$70K ﹤0.01%
+22,963
New +$65K
TAST
10285
CALL
DELISTED
Carrols Restaurant Group, Inc.
TAST
$70K ﹤0.01%
11,100
-13,700
-55% -$87.6K
HALL
10286
CALL
DELISTED
Hallmark Financial Services, Inc.
HALL
$70K ﹤0.01%
1,980
-40
-2% -$1.25K
SPPI
10287
CALL
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$70K ﹤0.01%
20,500
-45,700
-69% -$188K
GLOP
10288
CALL
DELISTED
GASLOG PARTNERS LP
GLOP
$70K ﹤0.01%
25,600
-24,000
-48% -$73.2K
AUTO
10289
DELISTED
AutoWeb, Inc. Common Stock
AUTO
$70K ﹤0.01%
28,537
+18,234
+177% +$56.5K
EMWP
10290
CALL
DELISTED
Eros Media World PLC
EMWP
$70K ﹤0.01%
1,925
-420
-18% -$18.3K
CMO
10291
PUT
DELISTED
Capstead Mortgage Corp.
CMO
$70K ﹤0.01%
12,100
-15,900
-57% -$90.8K
BSQR
10292
CALL
DELISTED
BSQUARE Corporation
BSQR
$70K ﹤0.01%
+46,000
New +$61.1K
GB.WS
10293
DELISTED
Global Blue Group Holding AG Warrants exercisable for one Ordinary Share of Global Blue Group Holding AG at a price of $11.50 per share
GB.WS
$69K ﹤0.01%
42,151
+694
+2% +$749
KZR
10294
PUT
DELISTED
Kezar Life Sciences
KZR
$69K ﹤0.01%
+1,330
New +$74K
PPSI
10295
Pioneer Power Solutions
PPSI
$34.5M
$69K ﹤0.01%
17,760
+6,562
+59% +$23.4K
REI icon
10296
Ring Energy
REI
$322M
$69K ﹤0.01%
104,125
+83,346
+401% +$54.9K
TRUE
10297
PUT
DELISTED
TrueCar
TRUE
$69K ﹤0.01%
+16,500
New +$73.6K
ENZ
10298
DELISTED
Enzo Biochem, Inc.
ENZ
$69K ﹤0.01%
27,435
-23,613
-46% -$51.4K
BIOC
10299
CALL
DELISTED
Biocept, Inc.
BIOC
$69K ﹤0.01%
+517
New +$73.7K
RLH
10300
DELISTED
Red Lions Hotel Corporation
RLH
$69K ﹤0.01%
+19,915
New +$44.7K

Similar funds

Citadel Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, Citadel Advisors held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Citadel Advisors withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.7% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Citadel Advisors opened a new position in S&P Global worth $114M.

  • Citadel Advisors's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
  • Citadel Advisors added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
  • Citadel Advisors's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
  • Citadel Advisors fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
  • Citadel Advisors's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
  • Citadel Advisors opened 1,989 new positions and closed 1,130 in Q4 2020.
  • Citadel Advisors's portfolio value rose 9.1% quarter-over-quarter to $385B.

Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.